Does Helicobacter pylori infection protect against esophageal diseases in Asia?

被引:3
|
作者
Wu J.C.Y. [1 ,2 ]
机构
[1] Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong
[2] Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong, 9/F, Clinical Science Building
关键词
Asian; Gastroesophageal reflux disease; Obesity;
D O I
10.1007/s12664-011-0124-6
中图分类号
学科分类号
摘要
The speculations on the protective role of Helicobacter pylori against gastroesophageal reflux disease (GERD) originated from epidemiological observations. These studies have shown that the rising trend of GERD is coincident with declining prevalence of H. pylori and peptic ulcer disease in Asia. Furthermore, most case-control and population-based studies suggest a negative association between H. pylori infection and GERD. It is generally believed that the preponderance of cagA+ and vacA+ virulent strains and proinflammatory interleukin-1 beta polymorphism increase the risk of hypochlohydria and protects against the development of GERD in Asian population. Recovery of gastric acid secretion and emergence of reflux esophagitis has been reported after H. pylori eradication in patients with corpus gastritis and atrophic gastritis. Recent studies have also reported that H. pylori eradication leads to recovery of ghrelin secreting cells in the gastric corpus and a rise in plasma ghrelin levels, which may contribute to obesity through its appetite-stimulating action and predispose to GERD. The prevalence of H. pylori infection is generally lower in younger Asians who enjoy improved socioeconomic status and sanitation compared with their older counterparts. The Asian population is probably facing a rising generation with high gastric acid and ghrelin secretion rates. These physiological changes may contribute to increased dietary calorie intake, obesity and increased prevalence of GERD. © 2011 Indian Society of Gastroenterology.
引用
收藏
页码:149 / 153
页数:4
相关论文
共 50 条
  • [21] Autoimmune diseases and Helicobacter pylori infection
    Gasbarrini, A
    Franceschi, F
    BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (5-6) : 223 - 226
  • [22] Helicobacter pylori infection in rheumatic diseases
    Hongyan Wen
    Jing Luo
    Junxia Li
    Xiaofeng Li
    Arthritis Research & Therapy, 14 (Suppl 1):
  • [23] Extradigestive diseases and Helicobacter pylori infection
    Patel, P
    Gasbarrini, G
    Pretolani, S
    Gasbarrini, A
    Franceschi, F
    CURRENT OPINION IN GASTROENTEROLOGY, 1997, 13 : 52 - 55
  • [24] Helicobacter pylori infection and dermatologic diseases
    Hernando-Harder, Ana C.
    Booken, Nina
    Goerdt, Sergij
    Singer, Manfred V.
    Harder, Hermann
    EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (05) : 431 - 444
  • [25] Helicobacter pylori infection and nonmalignant diseases
    Sjomina, Olga
    Heluwaert, Frederic
    Moussata, Driffa
    Leja, Marcis
    HELICOBACTER, 2017, 22
  • [26] Helicobacter pylori infection and skin diseases
    Wedi, B
    Kapp, A
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1999, 50 (05): : 753 - 776
  • [27] Helicobacter pylori infection and Nonmalignant Diseases
    de Vries, Annemarie C.
    Kuipers, Ernst J.
    HELICOBACTER, 2010, 15 : 29 - 33
  • [28] Helicobacter pylori infection and vascular diseases
    Gasbarrini, A
    Serricchio, M
    Tondi, P
    Franceschi, F
    Ojetti, V
    Torre, ES
    Candelli, M
    Gabrielli, M
    Fiore, G
    Pola, R
    Santoliquido, A
    Giacovazzo, M
    Gasbarrini, G
    Pola, P
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 30 : S307 - S309
  • [29] Helicobacter pylori infection and extragastroduodenal diseases
    Maev, I. V.
    Andreev, D. N.
    Kucheryavyi, Yu. A.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (08) : 103 - 110
  • [30] Helicobacter pylori infection in rheumatic diseases
    Wen, Hongyan
    Luo, Jing
    Li, Junxia
    Li, Xiaofeng
    ARTHRITIS RESEARCH & THERAPY, 2012, 14